All In Biotech

Drug Trial Radar · NCT07090161

Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension

Last checked: Nov 20, 2026Latest source record: Feb 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 240 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

240

Planned (sponsor's estimate)

Start

Sep 15, 2025

Primary completion

Oct 2026

Study completion Nov 2026

Sponsor

Lead sponsor
Vanda PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Jul 29, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Iloperidone for the Treatment of Participants with Uncontrolled Hypertension

Conditions

  • Hypertension
  • Uncontrolled Hypertension

Interventions

  • iloperidoneDrug

    iloperidone

  • PlaceboDrug

    placebo comparator

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline to treatment week 4 in SiSBPTime frame: screening to treatment week 4

Locations

28 sites in 1 country. Site status is shown where the registry gives one.

  • Vanda Investigative Site

    Phoenix, Arizona · Not yet recruiting

  • Vanda Investigative Site

    Tempe, Arizona · Recruiting

  • Vanda Investigative Site

    Tucson, Arizona · Not yet recruiting

  • Vanda Investigative Site

    Chula Vista, California · Recruiting

  • Vanda Investigative Site

    Dublin, California · Recruiting

  • Vanda Investigative Site

    Valencia, California · Not yet recruiting

  • Vanda Investigative Site

    Walnut Creek, California · Recruiting

  • Vanda Investigative Site

    Doral, Florida · Not yet recruiting

  • Vanda Investigative Site

    Fort Myers, Florida · Recruiting

  • Vanda Investigative Site

    Columbus, Georgia · Recruiting

  • Vanda Investigative Site

    Oak Brook, Illinois · Recruiting

  • Vanda Investigative Site

    Tinley Park, Illinois · Recruiting

  • Vanda Investigative Site

    El Dorado, Kansas · Recruiting

  • Vanda Investigative Site

    Wichita, Kansas · Recruiting

  • Vanda Investigative Site

    Lexington, Kentucky · Recruiting

  • Vanda Investigative Site

    Hazelwood, Missouri · Recruiting

  • Vanda Investigative Site

    Las Vegas, Nevada · Not yet recruiting

  • Vanda Investigative Site

    Mount Kisco, New York · Not yet recruiting

  • Vanda Investigative Site

    Rochester, New York · Not yet recruiting

  • Vanda Investigative Site

    Kinston, North Carolina · Recruiting

  • Vanda Investigative Site

    Cincinnati, Ohio · Recruiting

  • Vanda Investigative Site

    Norman, Oklahoma · Recruiting

  • Vanda Investigative Site

    Oklahoma City, Oklahoma · Not yet recruiting

  • Vanda Investigative Site

    Charleston, South Carolina · Recruiting

  • Vanda Investigative Site

    Carrollton, Texas · Not yet recruiting

  • Vanda Investigative Site

    Salt Lake City, Utah · Not yet recruiting

  • Vanda Investigative Site

    Burke, Virginia · Recruiting

  • Vanda Investigative Site

    Norfolk, Virginia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.